Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 77.20
0.00 (0.00%)
At close: May 29, 2026
Citi Pharma Ratios and Metrics
Market cap in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 17,637 | 19,184 | 6,511 | 4,875 | 7,457 | - | |
Market Cap Growth | -1.33% | 194.63% | 33.55% | -34.62% | - | - |
Enterprise Value | 20,879 | 20,807 | 6,236 | 4,443 | 5,627 | - |
Last Close Price | 77.20 | 80.81 | 25.42 | 17.15 | 26.24 | - |
PE Ratio | 16.08 | 21.51 | 7.81 | 7.41 | 11.41 | - |
Forward PE | 18.38 | 6.34 | 6.34 | 6.34 | - | - |
PS Ratio | 1.27 | 1.46 | 0.53 | 0.39 | 0.76 | - |
PB Ratio | 1.61 | 1.77 | 1.16 | 0.91 | 1.58 | - |
P/TBV Ratio | 1.61 | 1.77 | 1.16 | 0.91 | 1.58 | - |
P/FCF Ratio | - | - | 8.46 | - | - | - |
P/OCF Ratio | - | - | 4.87 | - | - | - |
EV/Sales Ratio | 1.51 | 1.58 | 0.50 | 0.36 | 0.57 | - |
EV/EBITDA Ratio | 9.19 | 11.78 | 4.65 | 3.53 | 5.28 | - |
EV/EBIT Ratio | 10.02 | 12.97 | 5.17 | 3.81 | 5.66 | - |
EV/FCF Ratio | -28.15 | - | 8.11 | - | - | - |
Debt / Equity Ratio | 0.33 | 0.27 | 0.26 | 0.34 | 0.20 | 0.07 |
Debt / EBITDA Ratio | 1.57 | 1.66 | 1.08 | 1.46 | 0.88 | 0.50 |
Debt / FCF Ratio | - | - | 1.89 | - | - | - |
Net Debt / Equity Ratio | 0.30 | 0.13 | 0.01 | 0.05 | -0.22 | -0.63 |
Net Debt / EBITDA Ratio | 1.43 | 0.77 | 0.03 | 0.21 | -0.99 | -4.36 |
Net Debt / FCF Ratio | -4.37 | -2.89 | 0.05 | -0.20 | 1.14 | 52.65 |
Asset Turnover | 0.85 | 0.88 | 1.16 | 1.37 | 1.34 | 1.29 |
Inventory Turnover | 2.65 | 3.12 | 3.72 | 5.06 | 6.82 | 6.02 |
Quick Ratio | 0.60 | 0.66 | 0.68 | 0.80 | 1.15 | 1.92 |
Current Ratio | 1.31 | 1.30 | 1.36 | 1.48 | 1.86 | 2.45 |
Return on Equity (ROE) | 13.28% | 10.81% | 15.14% | 13.05% | 14.40% | 13.16% |
Return on Assets (ROA) | 8.02% | 6.71% | 7.03% | 8.06% | 8.49% | 7.96% |
Return on Invested Capital (ROIC) | 9.93% | 11.81% | 13.88% | 17.27% | 23.24% | 26.99% |
Return on Capital Employed (ROCE) | 18.50% | 14.40% | 20.60% | 21.10% | 19.40% | 12.20% |
Earnings Yield | 6.22% | 4.65% | 12.80% | 13.50% | 8.77% | - |
FCF Yield | -4.21% | -2.45% | 11.82% | -26.33% | -12.38% | - |
Dividend Yield | 4.53% | 4.33% | 12.78% | 14.57% | - | - |
Payout Ratio | 72.92% | 82.94% | 68.53% | - | 47.66% | - |
Buyback Yield / Dilution | 0.07% | - | - | -0.70% | -21.65% | -88.38% |
Total Shareholder Return | 4.60% | 4.33% | 12.78% | 13.87% | -21.65% | -88.38% |